Bacillus subtilis

References

• Negri DR, Riccomi A, Pinto D, Vendetti S, Rossi A, Cicconi R, et al. Persistence of mucosal and systemic immune responses following sublingual immunization. Vaccine 2010; 28:4175 - 80; http://dx.doi.org/10.1016/j.vaccine.2010.04.013; PMID: 20412876
   PubMed Web of Science ®Google Scholar
• Yuki Y, Kiyono H. New generation of mucosal adjuvants for the induction of protective immunity.
   Google Scholar
• Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006; 6:148 - 58; http://dx.doi.org/10.1038/nri1777; PMID: 16491139
   PubMed Web of Science ®Google Scholar
• Cuburu N, Kweon MN, Song JH, Hervouet C, Luci C, Sun JB, et al. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 2007; 25:8598 - 610; http://dx.doi.org/10.1016/j.vaccine.2007.09.073; PMID: 17996991
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11:Suppl S45 - 53; http://dx.doi.org/10.1038/nm1213; PMID: 15812489
   PubMed Web of Science ®Google Scholar
• Lee S, Belitsky BR, Brown DW, Brinker JP, Kerstein KO, Herrmann JE, et al. Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C. Vaccine 2010; 28:6658 - 65; http://dx.doi.org/10.1016/j.vaccine.2010.08.016; PMID: 20709005
   PubMed Web of Science ®Google Scholar
• Armstrong ME, Lavelle EC, Loscher CE, Lynch MA, Mills KH. Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines. J Infect Dis 2005; 192:1628 - 33; http://dx.doi.org/10.1086/491739; PMID: 16206078
   PubMed Web of Science ®Google Scholar
• Lemiale F, Kong WP, Akyürek LM, Ling X, Huang Y, Chakrabarti BK, et al. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J Virol 2003; 77:10078 - 87; http://dx.doi.org/10.1128/JVI.77.18.10078-10087.2003; PMID: 12941918
   PubMed Web of Science ®Google Scholar
• Fujihashi K, Koga T, van Ginkel FW, Hagiwara Y, McGhee JR. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. Vaccine 2002; 20:2431 - 8; http://dx.doi.org/10.1016/S0264-410X(02)00155-X; PMID: 12057597
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11:Suppl S45 - 53; http://dx.doi.org/10.1038/nm1213; PMID: 15812489
   PubMed Web of Science ®Google Scholar
• BenMohamed L, Belkaid Y, Loing E, Brahimi K, Gras-Masse H, Druilhe P. Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant. Eur J Immunol 2002; 32:2274 - 81; http://dx.doi.org/10.1002/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO;2-C; PMID: 12209640
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 2002; 41:661 - 80; http://dx.doi.org/10.2165/00003088-200241090-00003; PMID: 12126458
   PubMed Web of Science ®Google Scholar
• Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu-Uvin S, et al. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol 2002; 169:566 - 74; PMID: 12077289
   PubMed Web of Science ®Google Scholar
• van Ginkel FW, Jackson RJ, Yuki Y, McGhee JR. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 2000; 165:4778 - 82; PMID: 11045998
   PubMed Web of Science ®Google Scholar
• Song JH, Nguyen HH, Cuburu N, Horimoto T, Ko SY, Park SH, et al. Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc Natl Acad Sci U S A 2008; 105:1644 - 9; http://dx.doi.org/10.1073/pnas.0708684105; PMID: 18227512
   PubMed Web of Science ®Google Scholar
• Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 1997; 65:1387 - 94; PMID: 9119478
   PubMed Web of Science ®Google Scholar
• Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005; 307:1920 - 5; http://dx.doi.org/10.1126/science.1106442; PMID: 15790845
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229 - 41; http://dx.doi.org/10.1016/j.cell.2004.07.002; PMID: 15260992
   PubMed Web of Science ®Google Scholar
• Hong HA, Duc H, Cutting SM. The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 2005; 29:813 - 35; http://dx.doi.org/10.1016/j.femsre.2004.12.001; PMID: 16102604
   PubMed Web of Science ®Google Scholar
• Green DH, Wakeley PR, Page A, Barnes A, Baccigalupi L, Ricca E, et al. Characterization of two Bacillus probiotics. Appl Environ Microbiol 1999; 65:4288 - 91; PMID: 10473456
   PubMed Web of Science ®Google Scholar
• Oggioni MR, Ciabattini A, Cuppone AM, Pozzi G. Bacillus spores for vaccine delivery. Vaccine 2003; 21:Suppl 2 S96 - 101; http://dx.doi.org/10.1016/S0264-410X(03)00207-X; PMID: 12763690
   PubMed Web of Science ®Google Scholar
• Negri DR, Riccomi A, Pinto D, Vendetti S, Rossi A, Cicconi R, et al. Persistence of mucosal and systemic immune responses following sublingual immunization. Vaccine 2010; 28:4175 - 80; http://dx.doi.org/10.1016/j.vaccine.2010.04.013; PMID: 20412876
   PubMed Web of Science ®Google Scholar
• Detmer A, Glenting J. Live bacterial vaccines--a review and identification of potential hazards. Microb Cell Fact 2006; 5:23; http://dx.doi.org/10.1186/1475-2859-5-23; PMID: 16796731
   PubMed Web of Science ®Google Scholar
• Izadpanah A, Dwinell MB, Eckmann L, Varki NM, Kagnoff MF. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol 2001; 280:G710 - 9; PMID: 11254498
   PubMed Web of Science ®Google Scholar
• Modlin JF. Poliomyelitis in the United States: the final chapter?. JAMA 2004; 292:1749 - 51; http://dx.doi.org/10.1001/jama.292.14.1749; PMID: 15479943
   PubMed Web of Science ®Google Scholar
• Levine MM, Kaper JB. Live oral vaccines against cholera: an update. Vaccine 1993; 11:207 - 12; http://dx.doi.org/10.1016/0264-410X(93)90019-T; PMID: 8438619
   PubMed Web of Science ®Google Scholar
• Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, et al, United States Rotavirus Vaccine Efficacy Group. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. Pediatrics 1996; 97:7 - 13; PMID: 8545227
   PubMed Web of Science ®Google Scholar
• Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998; 338:1405 - 12; http://dx.doi.org/10.1056/NEJM199805143382002; PMID: 9580647
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Kelsall BL. Freshly isolated Peyer’s patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med 1999; 190:229 - 39; http://dx.doi.org/10.1084/jem.190.2.229; PMID: 10432286
   PubMed Web of Science ®Google Scholar
• Wu HY, Weiner HL. Oral tolerance. Immunol Res 2003; 28:265 - 84; http://dx.doi.org/10.1385/IR:28:3:265; PMID: 14713719
   PubMed Web of Science ®Google Scholar
• Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A 1992; 89:421 - 5; http://dx.doi.org/10.1073/pnas.89.1.421; PMID: 1370356
   PubMed Web of Science ®Google Scholar
• Amuguni H, Lee S, Kerstein KO, Brown DW, Belitsky BR. HerrmannJE, Keusch GT,Sonenshein AL,Tzipori S. Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets. [Epub ahead of print] Microbes Infect 2011; PMID: 22198093
   PubMed Web of Science ®Google Scholar
• Bergquist C, Lagergård T, Holmgren J. Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate. Infect Immun 1997; 65:1579 - 83; PMID: 9125533
   PubMed Web of Science ®Google Scholar
• Johansson EL, Rask C, Fredriksson M, Eriksson K, Czerkinsky C, Holmgren J. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun 1998; 66:514 - 20; PMID: 9453604
   PubMed Web of Science ®Google Scholar
• Staats HF, Montgomery SP, Palker TJ. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses. AIDS Res Hum Retroviruses 1997; 13:945 - 52; http://dx.doi.org/10.1089/aid.1997.13.945; PMID: 9223410
   PubMed Web of Science ®Google Scholar
• Imaoka K, Miller CJ, Kubota M, McChesney MB, Lohman B, Yamamoto M, et al. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. J Immunol 1998; 161:5952 - 8; PMID: 9834076
   PubMed Web of Science ®Google Scholar
• Rudin A, Riise GC, Holmgren J. Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect Immun 1999; 67:2884 - 90; PMID: 10338495
   PubMed Web of Science ®Google Scholar
• Amuguni JH, Lee S, Kerstein KO, Brown DW, Belitsky BR, Herrmann JE, et al. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice. Vaccine 2011; 29:4778 - 84; http://dx.doi.org/10.1016/j.vaccine.2011.04.083; PMID: 21565244
   PubMed Web of Science ®Google Scholar
• Cuburu N, Kweon MN, Hervouet C, Cha HR, Pang YY, Holmgren J, et al. Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection. J Immunol 2009; 183:7851 - 9; http://dx.doi.org/10.4049/jimmunol.0803740; PMID: 19933861
   PubMed Web of Science ®Google Scholar
• Kildsgaard J, Brimnes J, Jacobi H, Lund K. Sublingual immunotherapy in sensitized mice. Ann Allergy Asthma Immunol 2007; 98:366 - 72; http://dx.doi.org/10.1016/S1081-1206(10)60884-8; PMID: 17458434
   PubMed Web of Science ®Google Scholar
• Duc H, Hong HA, Fairweather N, Ricca E, Cutting SM. Bacterial spores as vaccine vehicles. Infect Immun 2003; 71:2810 - 8; http://dx.doi.org/10.1128/IAI.71.5.2810-2818.2003; PMID: 12704155
   PubMed Web of Science ®Google Scholar
• Hoang TH, Hong HA, Clark GC, Titball RW, Cutting SM. Recombinant B. subtilis Expressing the Clostridium perfringens Alpha Toxoid Is a Candidate Orally Delivered Vaccine against Necrotic Enteritis. Infect Immun 2008 November 1, 2008; 76(11):5257-65.
   Google Scholar
• Boucher P, Sato H, Sato Y, Locht C. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein. Infect Immun 1994; 62:449 - 56; PMID: 7507893
   PubMed Web of Science ®Google Scholar
• Zhou Z, Xia H, Hu X, Huang Y, Li Y, Li L, et al. Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3 kDa confers protection against Clonorchis sinensis. Vaccine 2008; 26:1817 - 25; http://dx.doi.org/10.1016/j.vaccine.2008.02.015; PMID: 18329763
   PubMed Web of Science ®Google Scholar
• Turnbull PC. Anthrax vaccines: past, present and future. Vaccine 1991; 9:533 - 9; http://dx.doi.org/10.1016/0264-410X(91)90237-Z; PMID: 1771966
   PubMed Web of Science ®Google Scholar
• Hoa NT, Baccigalupi L, Huxham A, Smertenko A, Van PH, Ammendola S, et al. Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl Environ Microbiol 2000; 66:5241 - 7; http://dx.doi.org/10.1128/AEM.66.12.5241-5247.2000; PMID: 11097897
   PubMed Web of Science ®Google Scholar
• Senesi S, Celandroni F, Tavanti A, Ghelardi E. Molecular characterization and identification of Bacillus clausii Strains marketed for use in oral bacteriotherapy. Appl Environ Microbiol 2001; 67:834 - 9; http://dx.doi.org/10.1128/AEM.67.2.834-839.2001; PMID: 11157251
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, MacKichan ML, Singh M. Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng 2001; 18:69 - 85; http://dx.doi.org/10.1016/S1389-0344(01)00101-0; PMID: 11566599
   PubMedGoogle Scholar
• Huang J-M, Hong HA, Van Tong H, Hoang TH, Brisson A, Cutting SM. Mucosal delivery of antigens using adsorption to bacterial spores. Vaccine 2010; 28:1021 - 30; http://dx.doi.org/10.1016/j.vaccine.2009.10.127; PMID: 19914191
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Z. [Bacterial spore--a new vaccine vehicle--a review]. Wei Sheng Wu Xue Bao 2008; 48:413 - 7; PMID: 18479073
   PubMedGoogle Scholar
• The Trouble in Tracing Opportunistic Pathogens. Cholangitis due to Bacillus in a French Hospital Caused by a Strain Related to an Italian Probiotic?. Microb Ecol Health Dis 2000; 12:99 - 101; http://dx.doi.org/10.1080/089106000435491
   Google Scholar
• Wang J, Fung DY. Alkaline-fermented foods: a review with emphasis on pidan fermentation. Crit Rev Microbiol 1996; 22:101 - 38; http://dx.doi.org/10.3109/10408419609106457; PMID: 8817079
   PubMed Web of Science ®Google Scholar
• Raychaudhuri S, Rock KL. Fully mobilizing host defense: building better vaccines. Nat Biotechnol 1998; 16:1025 - 31; http://dx.doi.org/10.1038/3469; PMID: 9831030
   PubMed Web of Science ®Google Scholar
• Simon O, Vahjen W, Taras D. Potential of probiotics in pig nutrition. Feed Mix (2007) 15, pp. 2-3. 34.
   Google Scholar
• Hong HA, Duc H, Cutting SM. The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 2005; 29:813 - 35; http://dx.doi.org/10.1016/j.femsre.2004.12.001; PMID: 16102604
   PubMed Web of Science ®Google Scholar
• Barnes AG, Cerovic V, Hobson PS, Klavinskis LS. Bacillus subtilis spores: a novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen. Eur J Immunol 2007; 37:1538 - 47; http://dx.doi.org/10.1002/eji.200636875; PMID: 17474150
   PubMed Web of Science ®Google Scholar
• Duc H, Hong HA, Fairweather N, Ricca E, Cutting SM. Bacterial spores as vaccine vehicles. Infect Immun 2003; 71:2810 - 8; http://dx.doi.org/10.1128/IAI.71.5.2810-2818.2003; PMID: 12704155
   PubMed Web of Science ®Google Scholar
• Hoang TH, Hong HA, Clark GC, Titball RW, Cutting SM. Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis. Infect Immun 2008; 76:5257 - 65; http://dx.doi.org/10.1128/IAI.00686-08; PMID: 18779344
   PubMed Web of Science ®Google Scholar
• Bumann D, Hueck C, Aebischer T, Meyer TF. Recombinant live Salmonella spp. for human vaccination against heterologous pathogens. FEMS Immunol Med Microbiol 2000; 27:357 - 64; http://dx.doi.org/10.1111/j.1574-695X.2000.tb01450.x; PMID: 10727892
   PubMed Web of Science ®Google Scholar
• Casula G, Cutting SM. Bacillus probiotics: spore germination in the gastrointestinal tract. Appl Environ Microbiol 2002; 68:2344 - 52; http://dx.doi.org/10.1128/AEM.68.5.2344-2352.2002; PMID: 11976107
   PubMed Web of Science ®Google Scholar
• Duc H, Hong HA, Cutting SM. Germination of the spore in the gastrointestinal tract provides a novel route for heterologous antigen delivery. Vaccine 2003; 21:4215 - 24; http://dx.doi.org/10.1016/S0264-410X(03)00492-4; PMID: 14505901
   PubMed Web of Science ®Google Scholar
• Driks A. Bacillus subtilis spore coat. Microbiol Mol Biol Rev 1999; 63:1 - 20; PMID: 10066829
   PubMed Web of Science ®Google Scholar
• Rhee KJ, Sethupathi P, Driks A, Lanning DK, Knight KL. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J Immunol 2004; 172:1118 - 24; PMID: 14707086
   PubMed Web of Science ®Google Scholar
• Isticato R, Cangiano G, Tran HT, Ciabattini A, Medaglini D, Oggioni MR, et al. Surface display of recombinant proteins on Bacillus subtilis spores. J Bacteriol 2001; 183:6294 - 301; http://dx.doi.org/10.1128/JB.183.21.6294-6301.2001; PMID: 11591673
   PubMed Web of Science ®Google Scholar
• Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, et al. The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature 1997; 390:249 - 56; http://dx.doi.org/10.1038/36786; PMID: 9384377
   PubMed Web of Science ®Google Scholar
• Medaglini D, Ciabattini A, Spinosa MR, Maggi T, Marcotte H, Oggioni MR, et al. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine 2001; 19:1931 - 9; http://dx.doi.org/10.1016/S0264-410X(00)00434-5; PMID: 11228363
   PubMed Web of Science ®Google Scholar
• Robinson K, Chamberlain LM, Schofield KM, Wells JM, Le Page RW. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol 1997; 15:653 - 7; http://dx.doi.org/10.1038/nbt0797-653; PMID: 9219268
   PubMed Web of Science ®Google Scholar
• Trollfors B, Knutsson N, Taranger J, Mark A, Bergfors E, Sundh V, et al. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose. Eur J Pediatr 2006; 165:14 - 8; http://dx.doi.org/10.1007/s00431-005-1763-3; PMID: 16249929
   PubMed Web of Science ®Google Scholar
• Rappuoli R, Pizza M, Douce G, Dougan G. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol Today 1999; 20:493 - 500; http://dx.doi.org/10.1016/S0167-5699(99)01523-6; PMID: 10529776
   PubMedGoogle Scholar
• Ciabattini A, Parigi R, Isticato R, Oggioni MR, Pozzi G. Oral priming of mice by recombinant spores of Bacillus subtilis. Vaccine 2004; 22:4139 - 43; http://dx.doi.org/10.1016/j.vaccine.2004.05.001; PMID: 15474704
   PubMed Web of Science ®Google Scholar
• Lee S, Belitsky BR, Brinker JP, Kerstein KO, Brown DW, Clements JD, et al. Development of a Bacillus subtilis-based rotavirus vaccine. Clin Vaccine Immunol 2010; 17:1647 - 55; http://dx.doi.org/10.1128/CVI.00135-10; PMID: 20810679
   PubMed Web of Science ®Google Scholar
• Helting TB, Nau HH. Analysis of the immune response to papain digestion products of tetanus toxin. Acta Pathol Microbiol Immunol Scand C 1984; 92:59 - 63; PMID: 6711309
   PubMedGoogle Scholar
• Lavelle EC, O’Hagan DT. Delivery systems and adjuvants for oral vaccines. Expert Opin Drug Deliv 2006; 3:747 - 62; http://dx.doi.org/10.1517/17425247.3.6.747; PMID: 17076597
   PubMed Web of Science ®Google Scholar
• Chadwick S, Kriegel C, Amiji M. Delivery strategies to enhance mucosal vaccination. Expert Opin Biol Ther 2009; 9:427 - 40; http://dx.doi.org/10.1517/14712590902849224; PMID: 19344280
   PubMed Web of Science ®Google Scholar
• Mauriello EM, Duc H, Isticato R, Cangiano G, Hong HA, De Felice M, et al. Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner. Vaccine 2004; 22:1177 - 87; http://dx.doi.org/10.1016/j.vaccine.2003.09.031; PMID: 15003646
   PubMed Web of Science ®Google Scholar
• Byrne MP, Smith TJ, Montgomery VA, Smith LA. Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate. Infect Immun 1998; 66:4817 - 22; PMID: 9746584
   PubMed Web of Science ®Google Scholar
• Umland TC, Wingert LM, Swaminathan S, Furey WF, Schmidt JJ, Sax M. Structure of the receptor binding fragment HC of tetanus neurotoxin. Nat Struct Biol 1997; 4:788 - 92; http://dx.doi.org/10.1038/nsb1097-788; PMID: 9334741
   PubMedGoogle Scholar
• Emsley P, Fotinou C, Black I, Fairweather NF, Charles IG, Watts C, et al. The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding. J Biol Chem 2000; 275:8889 - 94; http://dx.doi.org/10.1074/jbc.275.12.8889; PMID: 10722735
   PubMed Web of Science ®Google Scholar
• Lacy DB, Stevens RC. Sequence homology and structural analysis of the clostridial neurotoxins. J Mol Biol 1999; 291:1091 - 104; http://dx.doi.org/10.1006/jmbi.1999.2945; PMID: 10518945
   PubMed Web of Science ®Google Scholar